Low Levels of p27 in Association With Deregulated p53-pRb Protein Status Enhance Tumor Proliferation and Chromosomal Instability in Non-Small Cell Lung Carcinomas
暂无分享,去创建一个
A. Papavassiliou | D. Kletsas | V. Gorgoulis | A. Kotsinas | N. Kastrinakis | C. Kittas | J. Bramis | G. Mariatos | A Kotsinas | A G Papavassiliou | P Kanavaros | C Kittas | V G Gorgoulis | E Tsoli | P Zacharatos | G Mariatos | N G Kastrinakis | S Kokotas | P Asimacopoulos | J Bramis | D Kletsas | E. Tsoli | P. Kanavaros | S. Kokotas | Panayotis Zacharatos | Panayotis Asimacopoulos
[1] M. Loda,et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. , 1997, Cancer research.
[2] S. Salama,et al. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] L. Jin,et al. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. , 1998, The American journal of pathology.
[4] H. Asaoku,et al. Protein Expression of Cell Cycle Regulator, p27Kip1, Correlates with Histopathological Grade of Non‐Hodgkin's Lymphoma , 1999, Japanese journal of cancer research : Gann.
[5] Kenneth Cowan,et al. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells , 1997, Oncogene.
[6] G. Landberg,et al. Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico‐pathological characterization , 1999, The Journal of pathology.
[7] J. Kato,et al. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 , 1999, Nature.
[8] L. Hengst,et al. Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.
[9] Yoshiro,et al. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. , 1994, The American journal of pathology.
[10] O. Cohen,et al. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[11] James M. Roberts,et al. Cyclin E-CDK2 is a regulator of p27Kip1. , 1997, Genes & development.
[12] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[13] M. Piris,et al. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index. , 1997, The American journal of pathology.
[14] V. Gorgoulis,et al. Expression of p16INK4A and alterations of the 9p21‐23 chromosome region in non‐small‐cell lung carcinomas: Relationship with tumor growth parameters and ploidy status , 2000, International journal of cancer.
[15] J. Minna,et al. Progress in understanding the molecular pathogenesis of human lung cancer. , 1998, Biochimica et biophysica acta.
[16] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[17] S. Jiang,et al. Tumor extension and cell proliferation in adenocarcinomas of the lung. , 1999, The American journal of pathology.
[18] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[19] Juan F. García,et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. , 1999 .
[20] G. Bradley,et al. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. , 1998, The American journal of pathology.
[21] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[22] M. Kitagawa,et al. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. , 1998, The American journal of pathology.
[23] M. Pagano,et al. Enhanced Ribosomal Association of p27Kip1 mRNA Is a Mechanism Contributing to Accumulation during Growth Arrest* , 1997, The Journal of Biological Chemistry.
[24] N. Takuwa,et al. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts , 1997, Molecular and cellular biology.
[25] N. Tanigawa,et al. Prognostic Significance of p27kip1 Protein Expression and Spontaneous Apoptosis in Patients with Colorectal Adenocarcinomas , 2000, Oncology.
[26] Amanda G Paulovich,et al. When Checkpoints Fail , 1997, Cell.
[27] James M. Roberts,et al. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury , 1998, Nature Medicine.
[28] R. Saito,et al. The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. , 1999, Lung cancer.
[29] M. Pagano,et al. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation , 1997, Leukemia.
[30] P. Seth,et al. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. , 1997, Cancer research.
[31] J. Massagué,et al. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. , 1995, Cancer research.
[32] James M. Roberts,et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.
[33] C. Bartram,et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. , 1995, Cancer research.
[34] D. Spandidos,et al. Relative expression of wild-type and activated ki-ras2 oncogene in colorectal carcinomas. , 1993, International journal of oncology.
[35] Esposito,et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. , 1997, Cancer research.
[36] J. Cheville,et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.
[37] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[38] James M. Roberts,et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. , 1998, Molecular cell.
[39] J. Palazzo,et al. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. , 1999, Cancer research.
[40] F. Shepherd,et al. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. , 1999, Cancer research.
[41] C. Prives,et al. The p53 pathway , 1999, The Journal of pathology.
[42] V. Zoumpourlis,et al. Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs) , 2000, Molecular medicine.
[43] J. Bartek,et al. p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression , 1997, Molecular and cellular biology.
[44] Y. Yatabe,et al. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. , 1998, Cancer research.
[45] T. Halazonetis,et al. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. , 1998, The American journal of pathology.
[46] R. Yeung,et al. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] S. Bohlander,et al. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. , 1996, Cancer research.
[48] L. Jin,et al. Aberrant p27kip1 expression in endocrine and other tumors. , 1997, The American journal of pathology.